Title : Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

Pub. Date : 2006 May

PMID : 16644314






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Switching to rosuvastatin produced greater reductions in LDL-C, total cholesterol, non-HDL-C, apolipoprotein B, and lipid ratios. Rosuvastatin Calcium apolipoprotein B Homo sapiens